重大事件
即時報告
8-K
2026-06-15
FATE Therapeutics提交8-K 披露股东会投票结果及高管补偿安排
AI 繁中摘要
FATE Therapeutics（FATE）於2026年6月15日提交8-K表格，報告2026年6月12日發生的兩項重要事件。第一，股東大會投票結果（Item 5.07）：會上通過了若干提案，具體內容需參閱附件。第二，高管離職或委任及補償安排（Item 5.02）：公司更新了部分高級職員的補償條款，相關協議詳見附件EX-10.1。這些變動可能影響公司薪酬結構及管理層穩定性。投資者應留意後續披露的細節，以評估對公司管治及營運的潛在影響。
展開英文正文
EDGAR Filing Documents for 0001193125-26-271055 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-271055 Filing Date 2026-06-15 Accepted 2026-06-15 16:02:48 Documents 10 Period of Report 2026-06-12 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K fate-20260612.htm iXBRL 8-K 87490 2 EX-10.1 fate-ex10_1.htm EX-10.1 518115 Complete submission text file 0001193125-26-271055.txt 784647 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fate-20260612.xsd EX-101.SCH 23928 13 EXTRACTED XBRL INSTANCE DOCUMENT fate-20260612_htm.xml XML 4521 Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803 FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings) EIN.: 651311552 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 261090711 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)